Old Web
English
Sign In
Acemap
>
authorDetail
>
R Lirio
R Lirio
Takeda Pharmaceutical Company
Physical therapy
Diabetes mellitus
Vedolizumab
Internal medicine
Medicine
3
Papers
12
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
DOP79 Effect of vedolizumab on surgical rates in IBD: post hoc analysis from the GEMINI trials
2019
Journal of Crohns & Colitis
Brian G. Feagan
Bruce E. Sands
R Lirio
Trevor Lissoos
J Wang
D Feng
Karen Lasch
Show All
Source
Cite
Save
Citations (1)
P441 Long-term immunogenicity of vedolizumab in ulcerative colitis and Crohn’s disease (GEMINI Programme)
2019
Journal of Crohns & Colitis
T. Wyant
Lili Yang
R Lirio
Maria Rosario
Show All
Source
Cite
Save
Citations (2)
OP26 Long-term safety of vedolizumab in ulcerative colitis and Crohn’s disease: final results from the GEMINI LTS study
2019
Journal of Crohns & Colitis
Severine Vermeire
J.-F. Colombel
Brian G. Feagan
William J. Sandborn
Bruce E. Sands
S. Danese
G. DHaens
Remo Panaccione
David T. Rubin
Ira Shafran
A Parfionovas
Raquel Rogers
R Lirio
Edward Vincent Loftus
Show All
Source
Cite
Save
Citations (9)
1